Scalable, automated bioreactor technology - engineered for the complexity of iPSC-based therapies.
Sterling Bio Machines is transforming how cell therapies are made. Our patent-pending bioreactor system is designed from the ground up for allogeneic workflows - where scale and consistency are non-negotiable. With an architecture built for automation and adaptability, we help developers bring high-quality cell therapies from bench to clinic, faster.
Scale with confidence. Sterling’s modular design supports identical workflows and controls from bench top to the clinic and commercial manufacturing - ensuring data integrity and predictable outcomes across every phase.
Smart sensors and integrated control systems enable real-time analytics and closed-loop automation, reducing human error and unlocking hands-free operation.
Sterling’s proprietary module maintains uniform cell aggregates - minimising shear stress and optimising both expansion and differentiation across every batch.
From academic labs to commercial production suites, our platform was built to meet the demands of today’s most advanced cell therapies.
Unlike traditional bioreactors, Sterling was purpose-built for pluripotent cells. We address the barriers that hold back scalable allogeneic production:
Our founders combine deep technical expertise with proven entrepreneurial leadership to bring the next generation of biomanufacturing to life.
A serial entrepreneur and founder of Interfolio, Steve has built and scaled platforms used by millions, now channeling that expertise into the bioeconomy.
A bioreactor visionary with patents in surgical robotics and 3D bio-printing, he brings precision engineering and real-world biomedical insight to the platform.
Sterling Bio Machines supports teams across the cell therapy ecosystem who are scaling breakthroughs into reality:
Developing cutting-edge iPSC-based therapies and seeking reliable platforms that don’t compromise speed or quality.
Needing scalable, standardised systems that enable tech transfer, process validation, and consistent yields.
Accelerating the path from discovery to clinical impact with plug-and-play automation and single-use simplicity.
Whether you're scaling a therapy or preparing for clinical trials,
Sterling helps you move faster with greater control.